Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

HIV Infection

Free Subscription Articles published in Antimicrob Agents Chemother Retrieve available abstracts of 102 articles: HTML format

Single Articles

June 2008
1. WANG G , Watson KM, Buckheit RW Jr
   Anti-HIV-1 Activity of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. ZAHM JA , Bera S, Pandey KK, Vora A, et al
   Mechanisms of Human Immunodeficiency Virus Type-1 Concerted Integration as related to Strand Transfer Inhibition and Drug Resistance.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. SCHULBIN H , Bode H, Stocker H, Schmidt W, et al
   Cytokine expression in the colonic mucosa of HIV-infected individuals before and during nine months of antiretroviral therapy.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. VAN ROMPAY KK , Durand-Gasselin L, Brignolo LL, Ray AS, et al
   Chronic administration of tenofovir to rhesus macaques from infancy throughout adulthood and pregnancy: summary of pharmacokinetics, biological and virological effects.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
5. DICENZO R , Peterson DR, Cruttenden K, Mariuz P, et al
   Effects of Minocycline and Valproic acid Coadministration on Atazanavir Plasma Concentrations in HIV-infected Adults Receiving Atazanavir/Ritonavir.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. PINNA D , Oreste P, Coradin T, Kajaste-Rudnitski A, et al
   Inhibition of Herpes Simplex Virus Type 1 and 2 In Vitro Infection by Sulfated Derivatives of K5 Escherichia coli Polysaccharide.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. WATSON KM , Buckheit CE, Buckheit RW Jr
   Comparative Evaluation of Virus Transmission Inhibition by Dual-Acting Pyrimidinedione Microbicides Using the Microbicide Transmission and Sterilization Assay (MTSA).
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
8. SAITOH A , Haas R, Naviaux R, Salva NG, et al
   Impact of Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on Mitochondrial DNA and RNA in Human Skeletal Muscle Cells.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
9. HOMBROUCK A , Van Remoortel B, Michiels M, Noppe W, et al
   Preclinical evaluation of 1H-benzylindole derivatives as novel HIV integrase strand transfer inhibitors.
   Antimicrob Agents Chemother. 2008;.
   PubMed     Related articles    Abstract available
   
   
   May 2008
10. STANKOV MV , Schmidt RE, Behrens GM
    Zidovudine impairs adipogenic differentiation through inhibition of clonal expansion.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. TERRAZAS-ARANDA K , Van Herrewege Y, Hazuda D, Lewi P, et al
    HIV-1 Integration: A Potential Target for Microbicides to Prevent Cell-free or Cell-associated Human Immunodeficiency Virus type-1 Infection.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    April 2008
12. LEK-UTHAI U , Suwanarusk R, Ruengweerayut R, Skinner-Adams TS, et al
    HIV-1 protease inhibitors and clinical isolates of Plasmodium: Greater activity against P. vivax than P. falciparum.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. FRANSEN S , Bridger G, Whitcomb JM, Toma J, et al
    Suppression of Dual-Tropic HIV-1 by the CXCR4 Antagonist AMD3100 is Associated with Efficiency of CXCR4 Use and Baseline Virus Composition.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
14. DURAND-GASSELIN L , Pruvost A, Dehee A, Vaudre G, et al
    High levels of AZT and its intracellular phosphate metabolites in AZT and AZT/3TC-treated newborns of HIV-infected mothers.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
15. ENDIMIANI A , Carias LL, Hujer AM, Bethel CR, et al
    Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae possessing blaKPC in the United States.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
16. VON HENTIG N , Kaykhin P, Stephan C, Babacan E, et al
    Decrease of atazanavir and lopinavir plasma concentrations in a boosted double HIV-protease inhibitor salvage regimen.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
17. ZHU M , Bifano M, Xu X, Wang Y, et al
    Lack of an Effect of HIV Co-Infection on the Pharmacokinetics of Entecavir in HBV Infected Patients.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
18. YANG G , Wang J, Cheng Y, Dutschman GE, et al
    Mechanism of Inhibition of HIV-1 Reverse Transcriptase by a Stavudine Analogue 4'-Ethynyl-D4TTP.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
19. AKKARAWONGSA R , Potocky TB, English E, Gellman SH, et al
    INHIBITION OF HERPES SIMPLEX VIRUS TYPE 1 INFECTION BY CATIONIC {beta}-PEPTIDES.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    March 2008
20. HOMBROUCK A , Voet A, Van Remoortel B, Desadeleer C, et al
    Mutations in HIV-1 Integrase Confer Resistance to the Naphthyridine L-870,810 and Cross Resistance to the Clinical Trial drug GS-9137.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
21. NAKATA H , Steinberg SM, Koh Y, Maeda K, et al
    Potent synergistic anti-HIV effects using combinations of a CCR5 inhibitor aplaviroc with other anti-HIV drugs.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
22. TELESHOVA N , Chang T, Profy A, Klotman ME, et al
    Inhibitory effect of PRO 2000, a candidate microbicide, on dendritic cell - mediated HIV transfer.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
23. KIM MJ , Jardel C, Barthelemy C, Jan V, et al
    Mitochondrial DNA content: an inaccurate biomarker of mitochondrial alteration in HIV-related lipodystrophy.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
24. LACKMAN-SMITH C , Osterling C, Luckenbaugh K, Mankowski M, et al
    Development of a Comprehensive Human Immunodeficiency Virus Type 1 (HIV-1) Screening Algorithm for Discovery and Preclinical Testing of Topical Microbicides.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
25. LIN PF , Nowicka-Sans B, Terry B, Zhang S, et al
    Entecavir Exhibits Inhibitory Activity Against HIV Under Conditions of Reduced Viral Challenge.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
26. RABAAOUI S , Zouhiri F, Lancon A, Leh H, et al
    Inhibitors of strand transfer that prevent integration and inhibit HTLV-1 early replication.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    February 2008
27. BARRAIL-TRAN A , Morand-Joubert L, Poizat G, Raguin G, et al
    Predictive value of the HIV phenotype and genotype and of amprenavir and lopinavir inhibitory quotients in heavily pretreated patients on a ritonavir-boosted dual protease inhibitor regimen.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
28. CAO YJ , Flexner CW, Dunaway S, Park JG, et al
    Effect of Low-dose Ritonavir on the Pharmacokinetics of the CXCR4 Antagonist AMD070 in Healthy Volunteers.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
29. KHARASCH ED , Mitchell D, Coles R, Blanco R, et al
    Rapid clinical induction of hepatic cytochrome P4502B6 (CYP2B6) activity by ritonavir.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
30. GHOSN J , De Montgolfier I, Cornelie C, Dominguez S, et al
    Antiretroviral therapy with indinavir 400 mg-ritonavir 100 mg twice daily containing regimen in HIV-1 infected women during pregnancy.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    January 2008
31. DESBOIS D , Roquebert B, Peytavin G, Damond F, et al
    In vitro Phenotypic Susceptibility of HIV-2 Clinical Isolates to Protease Inhibitors.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
32. MALET I , Delelis O, Valantin MA, Montes B, et al
    Mutations Associated with Failure of Raltegravir Treatment affect integrase sensitivity to the inhibitor in vitro.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
33. DEKHTYAR T , Ng TI, Lu L, Masse S, et al
    Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
34. PTAK RG , Gallay PA, Jochmans D, Halestrap AP, et al
    Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Cells by Debio-025, a Novel Cyclophilin Binding Agent.
    Antimicrob Agents Chemother. 2008;.
    PubMed     Related articles    Abstract available
    
    
    December 2007
35. GARVEY EP , Johns BA, Gartland MJ, Foster SA, et al
    The Naphthyridinone GSK364735 Is A Novel, Potent Human Immunodeficiency Virus-1 Integrase Inhibitor And Antiretroviral.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. NUTTALL JP , Thake DC, Lewis MG, Ferkany JW, et al
    Concentrations of Dapivirine in the Rhesus Macaque and Rabbit Following Once Daily Intravaginal Administration of a Gel Formulation of [14C]Dapivirine for 7 Days.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
37. BORKOW G , Lara HH, Covington CY, Nyamathi A, et al
    Deactivation of HIV-1 in Medium by Copper-Oxide Containing Filters.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
38. TANAKA R , Hanabusa H, Kinai E, Hasegawa N, et al
    Intracellular Efavirenz Levels in Peripheral Blood Mononuclear Cells from HIV-Infected Individuals.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
39. NICHOLS WG , Steel HM, Bonny T, Adkison K, et al
    Hepatotoxicity observed in clinical trials of aplaviroc (873140).
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. NAGULESWARAN A , Fialho AM, Chaudhari A, Hong CS, et al
    Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
41. CIHLAR T , Ray AS, Boojamra CG, Zhang L, et al
    Design and profiling of GS-9148, a novel nucleotide analog active against nucleoside-resistant HIV-1 variants, and its orally bioavailable phosphonoamidate prodrug GS-9131.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. RAY AS , Vela JE, Boojamra CG, Zhang L, et al
    Intracellular Metabolism of the Nucleotide Prodrug GS-9131 a Potent Anti-HIV Agent.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. FORD SL , Chen YC, Lou Y, Borland J, et al
    Pharmacokinetic Interaction between Fosamprenavir/Ritonavir and Rifabutin in Healthy Subjects.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    November 2007
44. LAMBERT-NICLOT S , Flandre P, Canestri A, Peytavin G, et al
    Factors associated with the selection of mutations conferring resistance to protease inhibitors in PI-experienced patients displaying treatment failure on darunavir.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. KISER JJ , Fletcher CV, Flynn PM, Cunningham CK, et al
    Pharmacokinetics of Antiretroviral Regimens Containing Tenofovir Disoproxil Fumarate and Atazanavir/Ritonavir in Adolescents and Young Adults with HIV Infection - Study ATN056.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. HANES JW , Johnson KA
    Exonuclease Removal of Dideoxycytidine (Zalcitabine) by the Human Mitochondrial DNA Polymerase.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    October 2007
47. BALESTRIERI E , Matteucci C, Ascolani A, Piperno A, et al
    Effect of phosphonated carbocyclic 2'-oxa-3'-aza-nucleoside on HTLV-1 infection in vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
48. SMITH RA , Gottlieb GS, Anderson DJ, Pyrak CL, et al
    HIV-1 and HIV-2 Exhibit Comparable Sensitivity to AZT and Other Nucleoside Analog Inhibitors In Vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
49. MARCHAND C , Beutler JA, Wamiru A, Budihas S, et al
    Madurahydroxylactone derivatives as dual inhibitors of HIV-1 integrase and RNase H.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
50. BUCKHEIT RW JR , Hartman TL, Watson KM, Chung SG, et al
    Comparative Evaluation of the Inhibitory Activity of a Series of Pyrimidinedione Congeners Which Inhibit Both HIV-1 and HIV-2.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
51. ZELINA S , Sheen CW, Radzio J, Mellors JW, et al
    MECHANISMS BY WHICH G333D IN HIV-1 REVERSE TRANSCRIPTASE FACILITATES DUAL RESISTANCE TO ZIDOVUDINE (AZT) AND LAMIVUDINE (3TC).
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
52. LAI W , Huang L, Ho P, Li Z, et al
    Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of HIV-1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
53. STAIB P , Lermann U, Blass-Warmuth J, Degel B, et al
    Tetracycline-inducible expression of individual Secreted Aspartic Proteases in Candida albicans allows isoenzyme-specific inhibitor screening.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. REDDY YS , Min SS, Borland J, Song I, et al
    Safety and Pharmacokinetics of GSK364735, an HIV-1 Integrase Inhibitor, Following Single and Repeat Administration in Healthy Adult Subjects.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
55. RODRIGUEZ-TUDELA JL , Almirante B, Rodriguez-Pardo D, Laguna F, et al
    Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
    Antimicrob Agents Chemother. 2007;51:3599-604.
    PubMed     Related articles    Abstract available
    
    
    
56. LIU P , Foster G, Gandelman K, LaBadie RR, et al
    Steady-state pharmacokinetic and safety profiles of voriconazole and ritonavir in healthy male subjects.
    Antimicrob Agents Chemother. 2007;51:3617-26.
    PubMed     Related articles    Abstract available
    
    
    September 2007
57. SAITOH A , Fenton T, Alvero C, Fletcher CV, et al
    Impact of Nucleoside Reverse Transcriptase Inhibitors on Mitochondria in HIV-1 Infected Children Receiving HAART.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
58. TREMOULET AH , Capparelli EV, Patel P, Acosta EP, et al
    Population Pharmacokinetics of Lamivudine in HIV Exposed and Infected Infants.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
59. BRADSHAW D , Malik S, Booth C, Van Houtte M, et al
    Characterization of a novel drug-resistance pattern associated with the mutations K70G and M184V in HIV-1 reverse transcriptase.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
60. VAN DER LEE MJ , Blenke AA, Rongen GA, Verwey-van Wissen CP, et al
    Combined use of paroxetine and fosamprenavir/ritonavir: an interaction study in healthy subjects.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
61. NTEMGWA M , Wainberg MA, Oliveira M, Moisi D, et al
    Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Show Divergent Phenotypic Resistance to Zidovudine.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. PAINTSIL E , Dutschman GE, Hu R, Grill SP, et al
    Intracellular Metabolism and Persistence of the Anti-Human Immunodeficiency Virus Activity of 2', 3'-Didehydro-3'-Deoxy-4'- Ethynylthymidine, A Novel Thymidine Analog.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. DOYLE PS , Zhou YM, Engel JC, McKerrow JH, et al
    A Cysteine Protease Inhibitor Cures Chagas' Disease in an, Immunodeficient Murine Model of Infection.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
64. WIRE MB , Ballow CH, Borland J, Shelton MJ, et al
    Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged.
    Antimicrob Agents Chemother. 2007;51:2982-4.
    PubMed     Related articles    Abstract available
    
    
    July 2007
65. FLYNN PM , Rodman J, Lindsey JC, Robbins B, et al
    Intracellular Pharmacokinetics of Once vs. Twice Daily Zidovudine and Lamivudine in Adolescents.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. TONG L , Phan TK, Robinson KL, Babusis D, et al
    Effects of HIV Protease Inhibitors on the Intestinal Absorption of Tenofovir Disoproxil Fumarate in vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. PAINTER GR , Almond MR, Trost LC, Lampert BM, et al
    EVALUATION OF HEXADECYLOXYPROPYL-9-R-[2-(PHOSPHONOMETHOXY)PROPYL]-ADENINE, CMX157, AS A POTENTIAL TREATMENT OF HIV-1 AND HEPATITIS B VIRUS INFECTIONS.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. BLAIR WS , Cao J, Jackson L, Jimenez J, et al
    Identification and Characterization of UK-201844, A Novel Inhibitor That Interferes with HIV-1 gp160 Processing.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. SMITH PF , Ogundele A, Forrest A, Wilton J, et al
    Phase I/II Study Of The Safety, Virologic Effect, And Pharmacokinetics/Pharmacodynamics Of Single Dose 3-O-(3',3'-dimethylsuccinyl) betulinic acid (Bevirimat) in HIV-Infection.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. DANDACHE S , Sevigny G, Yelle J, Stranix BR, et al
    In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Next Generation Protease Inhibitor of Human Immunodeficiency Virus Type 1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. FRANGEUL A , Barral K, Alvarez K, Canard B, et al
    In vitro Suppression of K65R Reverse Transcriptase-mediated Tenofovir- and Adefovir-5' Diphosphate Resistance Conferred by the Borano-phosphonate Derivatives.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
72. HAZEN R , Harvey R, Ferris R, Craig C, et al
    Evaluation of the In Vitro Antiviral Activity of the Novel, Tyrosyl-based Human Immunodeficiency Virus Type 1 Protease Inhibitor Brecanavir (BCV, GW640385, 385) in Combination with Other Antiretrovirals and Against a Panel of Protease Inhibitor-Resistant
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
73. CRESSEY TR , Nangola S, Tawon Y, Pattarawarapan M, et al
    An immunochromatographic strip test for the rapid detection of nevirapine in plasma samples of HIV-infected patients.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
74. CHEN L , Sabo JP, Philip E, Mao Y, et al
    Steady-state disposition of the nonpeptidic protease inhibitor tipranavir when coadministered with ritonavir.
    Antimicrob Agents Chemother. 2007;51:2436-44.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
75. SHI M , Wang X, De Clercq E, Takao S, et al
    Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
    Antimicrob Agents Chemother. 2007;51:2600-4.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
76. BORKOW G , Sidwell RW, Smee DF, Barnard DL, et al
    Neutralizing viruses in suspensions by copper oxide-based filters.
    Antimicrob Agents Chemother. 2007;51:2605-7.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    June 2007
77. MASSE S , Lu X, Dekhtyar T, Lu L, et al
    In vitro selection and characterization of human immunodeficiency virus type 2 (HIV-2) with decreased susceptibility to lopinavir.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
78. KING MS , Rode R, Cohen-Codar I, Calvez V, et al
    A predictive genotypic algorithm for virologic response to lopinavir/ritonavir in protease inhibitor-experienced patients.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
79. MARTIN DE , Blum R, Wilton J, Doto J, et al
    Safety and pharmacokinetics of Bevirimat (PA-457), a novel inhibitor of human immunodeficiency virus maturation, in healthy volunteers.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
80. LOTSCH J , Harder S, Geisslinger G, Sturmer M, et al
    Association of saquinavir plasma concentrations with side effects but not with antiretroviral outcome in patients infected with protease inhibitor susceptible HIV-1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
81. ACOSTA EP , Kendall MA, Gerber JG, Alston-Smith B, et al
    Effect of Concomitant Rifampin on the Pharmacokinetics and Safety of Twice-Daily Atazanavir: ACTG Protocol A5213.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
82. NAKATA H , Amano M, Koh Y, Kodama E, et al
    Antiviral Activity against HIV-1, Intracellular Metabolism, and Effects on Human DNA Polymerases of 4'-Ethynyl-2-fluoro-2'-deoxyadenosine.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
83. MULLER FM , Staudigel A, Salvenmoser S, Tredup A, et al
    Cross-Resistance between Medical and Agricultural Azole Drugs against Yeasts from the Oropharynx of HIV-Patients and from Environmental Bavarian Vine Grapes.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
84. MARCHAND B , White KL, Ly JK, Margot NA, et al
    EFFECTS OF THE TRANSLOCATION STATUS OF HIV-1 REVERSE TRANSCRIPTASE ON THE EFFICIENCY OF EXCISION OF TENOFOVIR.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
85. BETHELL R , De Muys J, Lippens J, Richard A, et al
    Evaluation of In Vitro Interactions Between Apricitabine and other Deoxycytidine Analogues.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
86. HEREDIA A , Gilliam B, Latinovic O, Le N, et al
    Rapamycin reduces CCR5 density levels on CD4 T cells and this effect results in potentiation of Enfuvirtide (T-20) against R5 HIV-1 in vitro.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
87. ASIF G , Hurwitz SJ, Obikhod A, Delinsky D, et al
    Pharmacokinetics of the Anti-HIV Agent 1-({beta}-D-Dioxolane)thymine in Rhesus Monkeys.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    April 2007
88. STICKNEY DR , Noveljic Z, Garsd A, Destiche DA, et al
    Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
89. BUGATTI A , Urbinati C, Ravelli C, De Clercq E, et al
    Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
90. STONE ND , Dunaway SB, Flexner CW, Tierney C, et al
    Multiple Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a selective CXCR4 Receptor Inhibitor, in Human Subjects (ACTG A5191).
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
91. CAI L , Gochin M
    A Novel Fluorescence Intensity Screening Assay Identifies New Low Molecular Weight Inhibitors of the gp41 Coiled Coil Domain of HIV-1.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
92. SERRANO-GOMEZ D , Martinez-Nunez RT, Sierra-Filardi E, Izquierdo N, et al
    Inmunoferon(R) modulates dendritic cell pathogen-recognition capabilities by targeting DC-SIGN.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
93. DURAND-GASSELIN L , Da Silva D, Benech H, Pruvost A, et al
    Evidence and possible consequences of the phosphorylation of NRTI in human red blood cells.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
94. ZORRILLA CD MD , Van Dyke R Md, Bardeguez A Md, Acosta EP Pharmd, et al
    Clinical Response, Safety and Tolerability to Saquinavir with Low-dose Ritonavir in HIV-1 Infected Mothers and their Infants: The PACTG 386.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
95. ROTH S , Monsour M, Dowland A, Guenthner PC, et al
    Effect of Topical Microbicides on Infectious HIV-1 Binding to Epithelial cells.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
96. LENNERSTRAND J , Chu CK, Schinazi RF
    Biochemical Studies on the Mechanism of HIV-1 Reverse Transcriptase Resistance to 1-({beta}-D-Dioxolane)thymine Triphosphate.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
97. HERNANDEZ-SANTIAGO BI , Mathew JS, Rapp KL, Grier JP, et al
    Antiviral and Cellular Metabolism Interactions between Dexelvucitabine and Lamivudine.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
98. VON HENTIG N , Muller A, Rottmann C, Wolf T, et al
    Pharmacokinetics of saquinavir, atazanavir, and ritonavir in a twice-daily boosted double-protease inhibitor regimen.
    Antimicrob Agents Chemother. 2007;51:1431-9.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    March 2007
99. MARIN-NIEBLA A , Lopez-Cortes LF, Ruiz-Valderas R, Viciana P, et al
    Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1200/100 mg) in naive or limited PI-experienced HIV-infected patients.
    Antimicrob Agents Chemother. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
100. AMANO M , Koh Y, Das D, Li J, et al
     A NOVEL bis-TETRAHYDROFURANYLURETHANE-CONTAINING NONPEPTIDIC PROTEASE INHIBITOR (PI) GRL-98065 POTENT AGAINST MULTI-PI-RESISTANT HIV IN VITRO.
     Antimicrob Agents Chemother. 2007;.
     PubMed     Related articles    Abstract available
     
     
     
101. MADARIAGA MG , Swindells S, McKee EE
     Oxazolidinones and human immunodeficiency virus.
     Antimicrob Agents Chemother. 2007;51:1130.
     PubMed     Related articles   
     
     
     January 2007
102. LARSEN RA , Bauer M, Brouwer AE, Sanchez A, et al
     In vitro-clinical correlations for amphotericin B susceptibility in AIDS-associated cryptococcal meningitis.
     Antimicrob Agents Chemother. 2007;51:343-5.
     PubMed     Related articles    Abstract available   Free Full Text
     
     

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Boehringer Ingelheim and Pfizer.

Amedeo is a Bernd Sebastian Kamps website.    Design: